018673730

SOZEMPA

---

March 16, 2022

Trademark Summary

The trademark application SOZEMPA was filed by Takeda Pharmaceuticals International AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on April 6, 2022, and it was registered by office on July 14, 2022 without any oppositions.

The application was filed in English (German was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with Pharmaceutical products and pharmaceutical preparations for the treatment of seizures associated with Dravet Syndrome and Lennox-Gastaut Syndrome..